Retailers Increase Return on Ad Spend From Google Product Listing Ads 89 Percent with Kenshoo Custom PLA Bid Policies

SAN FRANCISCO, Nov. 2, 2012/PRNewswire/ —

Using new functionality from Kenshoo, retailers find Product Listing Ads, Google Shopping’s new default ad type, more effective at driving online sales revenue

Kenshoo (http://www.kenshoo.com), a global leader in digital marketing software, today released key performance metrics based on the analysis of more than 270 million global impressions and clicks aggregated from merchants managing Google Product Listing Ads (PLAs) through Kenshoo during the first month following the release of new Kenshoo PLA functionality.

(Logo: http://photos.prnewswire.com/prnh/20120907/559592 )

“Kenshoo was first to market among SEM platforms with a PLA solution, and they’ve continued to deliver added-value functionality,” said Daniel Laury, President and CEO at Geary LSF Group. “Through Kenshoo, our teams are able to create and manage integrated PLA campaigns that deliver strong results.”

Overall, retailers managing PLAs through Kenshoo increased sales revenue driven by PLAs by 607 percent during the period, while increasing spending on PLAs by 348 percent. Further, retailers that activated Kenshoo custom PLA bid policies saw 89 percent improvement in return on ad spend. As Google transitions PLAs to be the default ad type for Google Shopping, top retailers have turned their attention toward and invested heavily to optimize Google’s PLA format, expanding the role of PLAs and often making the ad type a foundational element of comprehensive search programs.

Comparatively, Kenshoo found Google PLAs outperformed text search ads in many ways:

Click-through rate (CTR) was 73 percent higher
Conversion rate (CVR) was 35 percent higher
Average cost-per-click (CPC) was 36 percent lower
Return on ad spend (ROAS) was 46 percent higher

Kenshoo clients employing Kenshoo’s PLA bid policies boosted results further:

CTR increased by an additional 4 percent
CVR increased by an additional 34 percent
Average CPC decreased by an additional 31 percent
ROAS increased by an additional 89 percent

As Kenshoo covered in its recent quarterly report on global search advertising trends, Google Shopping moved to an all paid model in the U.S. on October 17, 2012, with the U.K. and Europe expected to follow in 2013. This means only merchants who leverage PLAs will appear in the search results, making these findings especially significant.

“Retailers using Kenshoo to manage PLAs saw impressive results leading to large increases in spend, and we expect these trends to continue in 2013 and beyond as marketers get more savvy using tools like Kenshoo to drive tangible results,” said Will Martin-Gill, General Manager of Kenshoo Enterprise and Kenshoo Local. “Marketers should consider these metrics when determining their campaign goals, especially since site traffic and sales will only continue to increase as the holiday season nears and they seek to engage consumers and expand visibility for their products.”

Kenshoo’s PLA enhancements include comprehensive product-level tracking, reporting, and management for Google Shopping as well as a custom PLA bid policy. Kenshoo’s patent-pending PLA offering eliminates the need for search marketers to manage tracking within data feeds. PLAs and Product Targets can be managed and tracked directly within the Kenshoo user interface. The Kenshoo algorithm clusters data based on historical performance and predicts PLA revenue per click to set bids. New Kenshoo reports such as the Fusion Report for Product Targets provide marketers with a holistic look at the performance of each PLA placement and its impact on sales conversions. Additionally, Kenshoo’s path-to-conversion reports show the interplay between PLAs and other channels for optimal attribution and bidding decisions. Finally, Kenshoo provides a negative keyword suggestion report for PLA campaigns to prevent irrelevant clicks, reduce costs and improve quality scores.

Please visit Kenshoo.com/PLA to view an infographic summarizing key PLA metrics from Kenshoo’s analysis and learn more about Kenshoo’s PLA functionality.

About Kenshoo

Kenshoo is a digital marketing software company that engineers technology solutions for search marketing, social media and online advertising. Brands, agencies and marketing providers use Kenshoo Enterprise, Kenshoo Local and Kenshoo Social to direct more than $25 billion in annual client sales revenue. The Kenshoo Universal Platform delivers automation, intelligence, integration and scale to make better marketing investments. With campaigns running in more than 190 countries, Kenshoo clients include CareerBuilder, Expedia, Facebook, KAYAK, Havas Digital, Hitwise, iREP, John Lewis, LendingTree, Resolution Media, Sears, Starcom MediaVest Group, Tesco, Travelocity, Walgreens, and Zappos. Kenshoo has 16 international locations and is backed by Sequoia Capital and Arts Alliance. Please visit http://www.Kenshoo.com for more information.

Kenshoo is a trademark of Kenshoo Ltd. Other company and brand names may be trademarks of their respective owners.

Retailers Increase Return on Ad Spend From Google Product Listing Ads 89 Percent with Kenshoo Custom PLA Bid Policies

SAN FRANCISCO, Nov. 2, 2012/PRNewswire/ —

Using new functionality from Kenshoo, retailers find Product Listing Ads, Google Shopping’s new default ad type, more effective at driving online sales revenue

Kenshoo (http://www.kenshoo.com), a global leader in digital marketing software, today released key performance metrics based on the analysis of more than 270 million global impressions and clicks aggregated from merchants managing Google Product Listing Ads (PLAs) through Kenshoo during the first month following the release of new Kenshoo PLA functionality.

(Logo: http://photos.prnewswire.com/prnh/20120907/559592 )

“Kenshoo was first to market among SEM platforms with a PLA solution, and they’ve continued to deliver added-value functionality,” said Daniel Laury, President and CEO at Geary LSF Group. “Through Kenshoo, our teams are able to create and manage integrated PLA campaigns that deliver strong results.”

Overall, retailers managing PLAs through Kenshoo increased sales revenue driven by PLAs by 607 percent during the period, while increasing spending on PLAs by 348 percent. Further, retailers that activated Kenshoo custom PLA bid policies saw 89 percent improvement in return on ad spend. As Google transitions PLAs to be the default ad type for Google Shopping, top retailers have turned their attention toward and invested heavily to optimize Google’s PLA format, expanding the role of PLAs and often making the ad type a foundational element of comprehensive search programs.

Comparatively, Kenshoo found Google PLAs outperformed text search ads in many ways:

Click-through rate (CTR) was 73 percent higher
Conversion rate (CVR) was 35 percent higher
Average cost-per-click (CPC) was 36 percent lower
Return on ad spend (ROAS) was 46 percent higher

Kenshoo clients employing Kenshoo’s PLA bid policies boosted results further:

CTR increased by an additional 4 percent
CVR increased by an additional 34 percent
Average CPC decreased by an additional 31 percent
ROAS increased by an additional 89 percent

As Kenshoo covered in its recent quarterly report on global search advertising trends, Google Shopping moved to an all paid model in the U.S. on October 17, 2012, with the U.K. and Europe expected to follow in 2013. This means only merchants who leverage PLAs will appear in the search results, making these findings especially significant.

“Retailers using Kenshoo to manage PLAs saw impressive results leading to large increases in spend, and we expect these trends to continue in 2013 and beyond as marketers get more savvy using tools like Kenshoo to drive tangible results,” said Will Martin-Gill, General Manager of Kenshoo Enterprise and Kenshoo Local. “Marketers should consider these metrics when determining their campaign goals, especially since site traffic and sales will only continue to increase as the holiday season nears and they seek to engage consumers and expand visibility for their products.”

Kenshoo’s PLA enhancements include comprehensive product-level tracking, reporting, and management for Google Shopping as well as a custom PLA bid policy. Kenshoo’s patent-pending PLA offering eliminates the need for search marketers to manage tracking within data feeds. PLAs and Product Targets can be managed and tracked directly within the Kenshoo user interface. The Kenshoo algorithm clusters data based on historical performance and predicts PLA revenue per click to set bids. New Kenshoo reports such as the Fusion Report for Product Targets provide marketers with a holistic look at the performance of each PLA placement and its impact on sales conversions. Additionally, Kenshoo’s path-to-conversion reports show the interplay between PLAs and other channels for optimal attribution and bidding decisions. Finally, Kenshoo provides a negative keyword suggestion report for PLA campaigns to prevent irrelevant clicks, reduce costs and improve quality scores.

Please visit Kenshoo.com/PLA to view an infographic summarizing key PLA metrics from Kenshoo’s analysis and learn more about Kenshoo’s PLA functionality.

About Kenshoo

Kenshoo is a digital marketing software company that engineers technology solutions for search marketing, social media and online advertising. Brands, agencies and marketing providers use Kenshoo Enterprise, Kenshoo Local and Kenshoo Social to direct more than $25 billion in annual client sales revenue. The Kenshoo Universal Platform delivers automation, intelligence, integration and scale to make better marketing investments. With campaigns running in more than 190 countries, Kenshoo clients include CareerBuilder, Expedia, Facebook, KAYAK, Havas Digital, Hitwise, iREP, John Lewis, LendingTree, Resolution Media, Sears, Starcom MediaVest Group, Tesco, Travelocity, Walgreens, and Zappos. Kenshoo has 16 international locations and is backed by Sequoia Capital and Arts Alliance. Please visit http://www.Kenshoo.com for more information.

Kenshoo is a trademark of Kenshoo Ltd. Other company and brand names may be trademarks of their respective owners.

National Foundation for Cancer Research and the Chinese Academy of Medical Sciences Host U.S.-China Symposium on State-of-Science Cancer Research and Future Direction for Global Collaboration

BETHESDA, Md. /PRNewswire/ — The National Foundation for Cancer Research (NFCR) and the Chinese Academy of Medical Sciences (CAMS) today announced that they will co-host a high-level symposium in Beijing November 4-6, 2012.
The U.S.-China Symposium on State-of-Science Cancer Research and Future Directions for Global Collaboration will bring together leading cancer researchers from the United States and China in an attempt to launch an actionable roadmap for international research collaboration that will accelerate innovative cancer research and discovery.
Leading cancer researchers from both academia and industry in China and the U.S. are committed to working together to create a platform of global collaboration for cancer drug-discovery and development.
This Symposium will be a transformative opportunity for shaping the future direction of cancer research in the U.S. and China. “Through stronger partnerships with our scientific and corporate colleagues in the United States, we hope to advance our efforts to build a more effective research platform for government and industry toward shared progress in research to cure cancer,” said Dr. Xuetao Cao, President of the Chinese Academy of Medical Sciences and co-host of the Symposium.
The topics addressed at this Symposium will help build bridges between and among cancer researchers regardless of field or national boundaries. “Developing action plans that foster global collaboration in cancer research will both accelerate scientific discoveries and their development into new therapies,” said Franklin Salisbury, Jr. President of the National Foundation for Cancer Research and co-host of the Symposium.
“We salute this type of synergistic collaboration across international borders, and are pleased to be a part of this Symposium,” said Dr. Sujuan Ba, President of the Asian Fund for Cancer Research and sponsor. Other sponsors include: AstraZeneca, Eli Lilly, and Cancer Institute & Hospital Chinese Academy of Medical Sciences.
Symposium Speakers and Format
The two-day Symposium will bring together prominent cancer researchers from government, academia, and industry to create a platform for global collaboration in cancer research that will foster scientific innovation and discovery.
A Plenary Session will feature Chinese Minister of Health Zhu Chen, M.D., Ph.D, and Anna Barker, Ph.D, Director, Arizona State University Transformative Healthcare Networks and former Deputy Director of the U.S. National Cancer Institute (NCI).
Other leading scientists participating in the Symposium include:
Steven Averbuch M.D., Bristol Myers Squibb
Anahita Bhathena, Ph.D., Abbott Laboratories
Xuetao Cao, M.D, Ph.D., Chinese Academy of Medical Sciences
Webster Cavenee, Ph.D., Ludwig Institute for Cancer Research
Shujun Cheng, M.D., Cancer Institute & Hospital Chinese Academy of Medical Sciences
Yung-Chi Cheng, Ph.D., Yale University Medical School
Carlo Croce, M.D., Ohio State University Medical Center
Jianren Gu, M.D., Ph.D., Shanghai Cancer Institute, Shanghai Jiao Tong University
Xi-Shan Hao, M.D., Chinese Anti-Cancer Association; Tianjin Medical University Cancer Institute
Waun Ki Hong, M.D., MD Anderson Cancer Center
Susan Horwitz, Ph.D., Albert Einstein College of Medicine
Scott Patterson, Ph.D., Amgen
George Sledge, Jr., Ph.D., Indiana University School of Medicine
Yan Sun, M.D., Cancer Institute & Hospital Chinese Academy of Medical Sciences
Zhaoyou Tang, M.D., Liver Cancer Institute, Fudan University
Peter Vogt, Ph.D., The Scripps Research Institute
Qimin Zhan, M.D., Chinese Academy of Medical Sciences
Symposium Topics will include:
Pathway for New Therapy Development in China and Vision for International Collaboration
Global Clinical Development Networks: 21st Century Approach to Clinical Trials
Biobanking and its Critical Role in Translational Cancer Research
Traditional Chinese Medicines and Natural Products: New Paradigm for Treating Cancer
Biomarkers and Molecular Medicines
Cancer Genome: Developing Genetic-Based Cancer Therapies
A Collaborative Initiative to Conquer GBM—A Model for International Collaboration
For a complete Symposium Program, and to see the full list of speakers, visit http://www.NFCR.org/symposium.
This Symposium is open by invitation and to accredited media. Journalists are encouraged to register with Silas Deane at (01) 615-319-6007 or sdeane@nfcr.org.
About the National Foundation for Cancer Research
The National Foundation for Cancer Research is a leading charity dedicated to funding innovative cancer research worldwide. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery, and since 1973 NFCR has spent over $300 million funding the “high risk/high reward” research responsible for many breakthroughs in cancer research. NFCR is committed to solving cancer’s molecular mysteries, and translating these discoveries into new approaches to preventing, diagnosing and treating cancer. NFCR is about Research for a Cure—cures for all types of cancer. For more information, please visit http://www.NFCR.org.
About the Chinese Academy of Medical Sciences
The Chinese Academy of Medical Sciences (CAMS) is the most important medical institution in China and is directly under the leadership of the Ministry of Health. The CAMS was created in 1956 by the Chinese government and was merged with Peking Union Medical College (PUMC) in Beijing. The mission of CAMS is to encourage high-quality research in biomedical science with the aim of improving people’s health and reducing the death rate, to offer the best clinical diagnoses and treatments for severe and rare diseases, to promote the transition of research to clinical applications, and to train first-rate medical professionals for research, clinical applications, and education. For more information, please visit, http://www.CAMS.ac.cn.
About the Asian Fund for Cancer Research
The Asian Fund for Cancer Research (AFCR) is committed to curing cancers that have significant impacts on Asian populations. Headquartered in Hong Kong, AFCR is dedicated to bridging the scientific and educational gaps in cancer research and cancer prevention between Asian countries and the rest of the world, through promoting, coordinating and funding international collaboration in cancer research and public education. AFCR is devoted to reducing the incidence and increasing the survival rate of cancers in Asia. For more information, please visit http://www.AFCR.org.hk.
Media Contact: Silas Deane
(01) 615-319-6007
sdeane@nfcr.org
Source: National Foundation for Cancer Research